Genprex, Inc. SEC filings GNPX
Genprex, Inc. has 491 filings in SEC EDGAR's recent list, going back to Dec 26, 2013. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Apr 29, 2026 | Jun 18, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2026 | Jun 18, 2026 |
| DEFA14A | Additional proxy material | Aug 4, 2025 | — |
| DEF 14A | Proxy statement | Jul 16, 2025 | Aug 15, 2025 |
| PRE 14A | Preliminary proxy statement | Jul 3, 2025 | Aug 15, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2024 | — |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jun 18, 2024 |
| DEFA14A | Additional proxy material | Nov 3, 2023 | — |
| DEF 14A | Proxy statement | Nov 3, 2023 | Dec 14, 2023 |
| PRE 14A | Preliminary proxy statement | Oct 23, 2023 | Dec 14, 2023 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 27, 2023 |
| DEFA14A | Additional proxy material | May 5, 2022 | — |
| DEFA14A | Additional proxy material | Apr 28, 2022 | — |
| DEF 14A | Proxy statement | Apr 28, 2022 | Apr 28, 2022 |
| PRE 14A | Preliminary proxy statement | Apr 14, 2022 | Jun 23, 2022 |
| DEFA14A | Additional proxy material | Apr 30, 2021 | — |
| DEF 14A | Proxy statement | Apr 30, 2021 | Jun 24, 2021 |
| DEFA14A | Additional proxy material | Apr 30, 2020 | — |
| DEF 14A | Proxy statement | Apr 29, 2020 | Jun 18, 2020 |
| DEF 14A | Proxy statement | Dec 23, 2019 | Dec 11, 2019 |
| PRE 14A | Preliminary proxy statement | Dec 10, 2019 | Jan 27, 2020 |
| DEF 14A | Proxy statement | Apr 30, 2019 | Jun 10, 2019 |
| DEF 14A | Proxy statement | Aug 29, 2018 | Oct 1, 2018 |
| PRE 14A | Preliminary proxy statement | Aug 16, 2018 | Oct 1, 2018 |
Showing 25 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- GNPX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- TX
- Headquarters
- Austin, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1595248
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.